Two Biotechs Blast Off
In the wake of COVID-19, biotech companies are racing to find a treatment. And one company could be sitting on a powerful anti-COVID-19 therapy as we speak. Plus, another one of your biotech names just shut up to triple digits!
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication(s) below and get access today!
Ray Blanco’s FDA Trader
Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.